Suleyman Kaleli

7PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 22, 2025
Genistein enhances TLR3-mediated apoptosis and immune signaling in breast cancer cells.

Suleyman Kaleli, Asuman Deveci Ozkan, Gamze Guney Eskiler

|Nov 26, 2021
Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro.

Asuman Deveci Ozkan, Gamze Guney Eskiler, Suleyman Kaleli

|May 03, 2021
Efficacy of 5-aminolevulinic acid-based photodynamic therapy in different subtypes of canine mammary gland cancer cells.

Ozge Turna, Aslihan Baykal, Elif Sozen Kucukkara

|Jan 30, 2021
Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer.

Zeynep Ozman, Betul Ozbek Iptec, Elvan Sahin

|Oct 30, 2020
Evaluation of the Effects of Nobiletin on Toll-Like Receptor 3 Signaling Pathways in Prostate Cancer In Vitro.

Asuman Deveci Ozkan, Mehmet Sarihan, Suleyman Kaleli

Pageof 2